Who owns Karyopharm Therapeutics?
- Ticker: KPTI
- CUSIP Number: 48576u106
Tip: Access positions for across all investors
Analyze quarterly positions in Karyopharm Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Karyopharm Therapeutics stock
Who bought or sold Karyopharm Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 8.7M | $7.5M | -1% | Dec 2023 |
|
| Avidity Partners Management | 8.3M | $7.2M | 0% | Dec 2023 |
|
| Palo Alto Investors | 5.1M | $4.4M | -10% | Dec 2023 |
|
| Citadel Advisors | 3.1M | $2.7M | 0% | Dec 2023 |
|
| GSA Capital Partners | 2.3M | $2.0M | 311% | Dec 2023 |
|
| Marshall Wace | 1.9M | $1.7M | -12% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.8M | $1.5M | 7% | Dec 2023 |
|
| Millennium Management | 1.5M | $1.3M | 23% | Dec 2023 |
|
| CAM Group Holding A/S | 1.5M | $1.3M | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 1.3M | $1.2M | 2179% | Dec 2023 |
|
| Goldman Sachs Group | 1.3M | $1.1M | -32% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.2M | $1.0M | 4% | Dec 2023 |
|
| AlphaCentric Advisors | 1.1M | $1.7M | 0% | Mar 2024 |
|
| Tejara Capital | 1.0M | $892k | -4% | Dec 2023 |
|
| Barclays | 970k | $838k | -16% | Dec 2023 |
|
| D. E. Shaw & Co | 617k | $534k | -1% | Dec 2023 |
|
| AQR Capital Management | 598k | $506k | 19% | Dec 2023 |
|
| Candriam Luxembourg S.C.A. | 531k | $459k | -53% | Dec 2023 |
|
| Bank of New York Mellon | 487k | $736k | -2% | Mar 2024 |
|
| UBS Group | 457k | $396k | -50% | Dec 2023 |
|
| Ikarian Capital | 400k | $346k | 0% | Dec 2023 |
|
| Thomas Stevens, CFA" | 388k | $585k | -1% | Mar 2024 |
|
| Charles Schwab Investment Management | 310k | $268k | 20% | Dec 2023 |
|
| Bank of America Corporation | 307k | $265k | -13% | Dec 2023 |
|
| Jacobs Levy Equity Management | 285k | $246k | -88% | Dec 2023 |
|
| Jane Street | 276k | $238k | 100% | Dec 2023 |
|
| PanAgora Asset Management | 227k | $197k | 100% | Dec 2023 |
|
| Exchange Traded Concepts | 213k | $321k | 84% | Mar 2024 |
|
| Alliancebernstein | 193k | $167k | 0% | Dec 2023 |
|
| DAFNA Capital Management | 193k | $167k | 0% | Dec 2023 |
|
| Nomura Holdings | 182k | $158k | -10% | Dec 2023 |
|
| Alyeska Investment Group | 145k | $125k | 100% | Dec 2023 |
|
| Two Sigma Investments | 142k | $123k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 138k | $119k | 0% | Dec 2023 |
|
| Monashee Investment Management | 132k | $35k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 87k | $76k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 76k | $69k | -1% | Dec 2023 |
|
| SG Americas Securities | 73k | $64k | 295% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 71k | $62k | 102% | Dec 2023 |
|
| Two Sigma Advisers | 63k | $55k | 80% | Dec 2023 |
|
| American International | 56k | $49k | 0% | Dec 2023 |
|
| Simplex Trading | 56k | $84k | 167% | Mar 2024 |
|
| Hsbc Holdings | 45k | $39k | 1% | Dec 2023 |
|
| GW & Wade | 45k | $39k | 0% | Dec 2023 |
|
| Simplicity Wealth | 44k | $67k | 100% | Mar 2024 |
|
| Bleakley Financial Group | 38k | $33k | 100% | Dec 2023 |
|
| Sawtooth Asset Management | 38k | $33k | 100% | Dec 2023 |
|
| Kennedy Investment Group | 35k | $53k | 0% | Mar 2024 |
|
| Principal Financial Group | 31k | $27k | -4% | Dec 2023 |
|
| Redwood Wealth Management Group | 30k | $26k | -9% | Dec 2023 |
|
| Florida State Board of Administration | 29k | $26k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 29k | $25k | 29% | Dec 2023 |
|
| State of Wyoming | 28k | $25k | -30% | Dec 2023 |
|
| Wexford Capital | 27k | $24k | 100% | Dec 2023 |
|
| Banque Cantonale Vaudoise | 25k | $38k | 0% | Mar 2024 |
|
| ELCO Management | 23k | $20k | 0% | Dec 2023 |
|
| Point72 Middle East FZE | 22k | $19k | -77% | Dec 2023 |
|
| Wolverine Trading | 20k | $17k | -2% | Dec 2023 |
|
| Two Sigma Securities | 20k | $17k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 19k | $17k | -1% | Dec 2023 |
|
| Diversified Trust Company | 19k | $28k | 0% | Mar 2024 |
|
| Citigroup | 16k | $14k | 924% | Dec 2023 |
|
| Winthrop Advisory Group | 15k | $23k | 100% | Mar 2024 |
|
| CI Private Wealth | 14k | $12k | 100% | Dec 2023 |
|
| Baird Financial | 14k | $12k | 0% | Dec 2023 |
|
| Legal & General Group | 14k | $12k | 0% | Dec 2023 |
|
| Neuberger Berman Group | 13k | $12k | 19% | Dec 2023 |
|
| Creative Planning | 12k | $10k | 0% | Dec 2023 |
|
| Bayesian Capital Management | 11k | $9.6k | 100% | Dec 2023 |
|
| Snowden Capital Advisors | 11k | $9.5k | 100% | Dec 2023 |
|
| Orion Portfolio Solutions | 11k | $10k | -16% | Dec 2023 |
|
| Virtu Financial | 10k | $9.0k | 100% | Dec 2023 |
|
| Janney Montgomery Scott | 10k | $9.0k | 0% | Dec 2023 |
|
| Russell Investments | 6.5k | $5.6k | -93% | Dec 2023 |
|
| Advisor Group Holdings | 6.4k | $5.6k | -7% | Dec 2023 |
|
| Summit Investment Advisors | 6.2k | $5.4k | 0% | Dec 2023 |
|
| Cubist Systematic Strategies | 4.7k | $4.1k | 100% | Dec 2023 |
|
| Pnc Financial Services | 3.0k | $2.6k | 0% | Dec 2023 |
|
| Amalgamated Bank | 2.5k | $4.0k | -83% | Mar 2024 |
|
| TD Waterhouse Canada | 2.1k | $1.7k | 0% | Dec 2023 |
|
| Founders Capital Management | 2.0k | $3.0k | 0% | Mar 2024 |
|
| Harbour Investments | 1.3k | $1.1k | 0% | Dec 2023 |
|
| Bruce G. Allen Investments | 507.00 | $765.975600 | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 500.00 | $755.000000 | 0% | Mar 2024 |
|
| Advisory Services Network | 500.00 | $433.000000 | 100% | Dec 2023 |
|
| AdvisorNet Financial | 200.00 | $302.000000 | -71% | Mar 2024 |
|
| West Branch Capital | 48.00 | $72.998400 | 0% | Mar 2024 |
|
| JJJ Advisors | 17.00 | $25.999800 | 0% | Mar 2024 |
|
| CWM | 12.00 | $0 | 300% | Mar 2024 |
|
| Zurcher Kantonalbank | 6.00 | $9.000000 | 0% | Mar 2024 |
|
| Financial Gravity Wealth | 2.00 | $2.000000 | 0% | Dec 2023 |
|
Who sold out of Karyopharm Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AIGH Capital Management | Sep 2023 | 1.8M | $2.4M |
| Parkwood | Sep 2023 | 1.0M | $661k |
| Worth Venture Partners | Sep 2023 | 446k | $598k |
| J. Goldman & Co | Sep 2023 | 120k | $161k |
| ALPS Advisors | Sep 2023 | 84k | $113k |
| Graham Capital Management | Sep 2023 | 82k | $110k |
| MetLife Investment Advisors | Sep 2023 | 60k | $81k |
| Centiva Capital | Sep 2023 | 46k | $61k |
| Squarepoint Ops | Sep 2023 | 34k | $46k |
| Weiss Multi-strategy Advisers | Dec 2023 | 27k | $23k |
| Brevan Howard Capital Management | Sep 2023 | 23k | $31k |
| Headlands Technologies | Sep 2023 | 14k | $19k |
| Victory Capital Management | Sep 2023 | 11k | $15k |
| Metropolitan Life Insurance Company | Sep 2023 | 6.2k | $8.4k |
| China Universal Asset Management | Sep 2023 | 2.9k | $4.0k |
| NISA Investment Advisors | Sep 2023 | 800.00 | $1.1k |
| Point72 Asset Management | Sep 2023 | 272.00 | $363.990400 |
| Daiwa Securities Group | Sep 2023 | 138.00 | $0 |